Atara biotherapeutics qtrly loss per share $1.36

Atara biotherapeutics announces fourth quarter and full year 2019 financial results and recent clinical, operational and strategic progress.qtrly loss per share $1.36.q4 earnings per share view $-1.34 -- refinitiv ibes data.

ATRA Ratings Summary

ATRA Quant Ranking